- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge extends European CAD sales
Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy.
Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy. The new markets represent the extension of an existing distribution agreement between the two companies addressing CADstream sales in the European Union. Merge has been ramping up educational efforts for EU radiologist, holding workshops on breast MRI in Germany and the U.K., and scheduling a course this month in France in November. CADstream joined the Merge portfolio with the acquisition earlier this year of its developer, Confirma, which is now the Merge CAD business unit. CADstream automates the analysis and interventional guidance of MRI studies. The company claims 1200 installed sites worldwide.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
